These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

241 related articles for article (PubMed ID: 3455931)

  • 1. Relationship between HLA-DR expression by normal myeloid progenitor cells and inhibition of colony growth by prostaglandin E. Implications for prostaglandin E resistance in chronic myeloid leukemia.
    Cannistra SA; Herrmann F; Davis R; Nichols K; Griffin JD
    J Clin Invest; 1986 Jan; 77(1):13-20. PubMed ID: 3455931
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of adult human marrow hematopoietic progenitors highly enriched by two-color cell sorting with My10 and major histocompatibility class II monoclonal antibodies.
    Lu L; Walker D; Broxmeyer HE; Hoffman R; Hu W; Walker E
    J Immunol; 1987 Sep; 139(6):1823-9. PubMed ID: 3114377
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential expression of class II MHC antigens in subpopulations of human hematopoietic progenitor cells.
    Ottmann OG; Nocka KH; Moore MA; Pelus LM
    Leukemia; 1988 Oct; 2(10):677-86. PubMed ID: 3172844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of interferon-gamma on HLA class II antigen expression and sensitivity to prostaglandin E1 by normal and leukemic myeloid progenitors.
    Aglietta M; Piacibello W; Stacchini A; Sanavio F; Infelise V; Resegotti L; Gavosto F
    Leuk Res; 1988; 12(4):299-303. PubMed ID: 3131593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of Ia antigens on myeloid progenitor cells in chronic myeloid leukemia: direct analysis using partially purified colony-forming cells.
    Cannistra SA; Daley JF; Larcom P; Griffin JD
    Blood; 1985 Feb; 65(2):414-22. PubMed ID: 3855362
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of HLA class II (DR, DQ) determinants by normal and chronic myeloid leukemia granulocyte/monocyte progenitors.
    Aglietta M; Piacibello W; Stacchini A; Dezza L; Sanavio F; Malavasi F; Infelise V; Resegotti L; Gavosto F
    Cancer Res; 1986 Apr; 46(4 Pt 1):1783-7. PubMed ID: 3456268
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Granulocyte/macrophage progenitor cells from peripheral blood and bone marrow differ in their response to prostaglandin E1.
    Richman CM; Johnson GD
    Blood; 1987 Dec; 70(6):1792-6. PubMed ID: 3499944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased DR antigen expression by committed hemopoietic progenitor cells but not primitive progenitor cells in chronic myeloid leukemia.
    Dowding CR; Gordon MY; Goldman JM
    Exp Hematol; 1988 Mar; 16(3):171-5. PubMed ID: 3422191
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential expression of HLA-DR antigens in subsets of human CFU-GM.
    Griffin JD; Sabbath KD; Herrmann F; Larcom P; Nichols K; Kornacki M; Levine H; Cannistra SA
    Blood; 1985 Oct; 66(4):788-95. PubMed ID: 3929858
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of Ia-antigens on normal and chronic myeloid leukemic human granulocyte-macrophage colony-forming cells (CFU-GM) is associated with the regulation of cell proliferation by prostaglandin E.
    Pelus LM; Saletan S; Silver RT; Moore MA
    Blood; 1982 Feb; 59(2):284-92. PubMed ID: 6173083
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of recombinant human tumor necrosis factor on highly enriched hematopoietic progenitor cell populations from normal human bone marrow and peripheral blood and bone marrow from patients with chronic myeloid leukemia.
    Wisniewski D; Strife A; Atzpodien J; Clarkson BD
    Cancer Res; 1987 Sep; 47(18):4788-94. PubMed ID: 3040231
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma.
    Broxmeyer HE; Williams DE; Lu L; Cooper S; Anderson SL; Beyer GS; Hoffman R; Rubin BY
    J Immunol; 1986 Jun; 136(12):4487-95. PubMed ID: 3086433
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between colony forming units-granulocyte macrophage expression of Ia-like (HLA-DR) antigen and control of granulocyte and macrophage production. A new role for prostaglandin E.
    Pelus LM
    J Clin Invest; 1982 Sep; 70(3):568-78. PubMed ID: 6286727
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Restoration of responsiveness of chronic myeloid leukemia granulocyte-macrophage colony-forming cells to growth regulation in vitro following preincubation with prostaglandin E.
    Pelus LM; Gold E; Saletan S; Coleman M
    Blood; 1983 Jul; 62(1):158-65. PubMed ID: 6574794
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of the expression of HLA-DR (Ia) antigens and the proliferation of human erythroid (BFU-E) and multipotential (CFU-GEMM) progenitor cells by prostaglandin E.
    Lu L; Pelus LM; Broxmeyer HE
    Exp Hematol; 1984 Oct; 12(9):741-8. PubMed ID: 6436046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Discordant maturation as the primary biological defect in chronic myelogenous leukemia.
    Strife A; Lambek C; Wisniewski D; Wachter M; Gulati SC; Clarkson BD
    Cancer Res; 1988 Feb; 48(4):1035-41. PubMed ID: 3422181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigenic characteristics of circulating CFU-GM in chronic granulocytic leukaemia resemble those of CFU-GM in normal marrow and differ from those in normal blood.
    Robak T; Nolasco I; Hibbin J; Goldman JM
    Leuk Res; 1985; 9(8):1023-9. PubMed ID: 2413317
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-DR monoclonal antibodies inhibit the proliferation of normal and chronic granulocytic leukaemia myeloid progenitor cells.
    Goldman JM; Hibbin J; Kearney L; Orchard K; Th'ng KH
    Br J Haematol; 1982 Nov; 52(3):411-20. PubMed ID: 6957244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the in vitro behavior of phenotypically defined populations of umbilical cord blood hematopoietic progenitor cells.
    Traycoff CM; Abboud MR; Laver J; Brandt JE; Hoffman R; Law P; Ishizawa L; Srour EF
    Exp Hematol; 1994 Feb; 22(2):215-22. PubMed ID: 7507862
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of the proliferation of human marrow erythroid (BFU-E) progenitor cells by prostaglandin E requires the participation of OKT8-positive T lymphocytes and is associated with the density expression of major histocompatibility complex class II antigens on BFU-E.
    Lu L; Pelus LM; Broxmeyer HE; Moore MA; Wachter M; Walker D; Platzer E
    Blood; 1986 Jul; 68(1):126-33. PubMed ID: 3487351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.